Mark Gilreath - EndoChoice Holdings Insider

GI -- USA Stock  

USD 8.00  8.00  9,223,372,036,855%

Mr. Mark G. Gilreath is Chief Executive Officer and Director of the company. He formed EndoChoice in October 2007 and has served since then as its President and Chief Executive Officer and member of the board of directors. Prior to founding EndoChoice Mr. Gilreath served from 1999 to 2008 on the Executive Committee at Given Imaging as President of the Americas and Chief Marketing Officer. During his 8 years at Given Imaging the company launched the PillCam Video Capsule and was transformed from a prerevenue startup to a Nasdaqlisted company delivering 120 million in annual revenue all through organic growth. From 1992 to 1999 He served in commercial leadership roles for PENTAX Medical a public company manufacturing video endoscopes for GI endoscopy. Prior to joining PENTAX from 1989 to 1992 He served in the U.S. Navy in naval intelligence including during Operation Desert Storm. He holds an MBA from the Fuqua School of Business at Duke University and a B.Sc. in business finance from Winthrop University. Mr. Gilreath currently serves on the board of directors of the FuquaCoach K Center on Leadership Ethics the Metro Atlanta Chamber of Commerce and the Medical Device Manufacturers Association .
Age: 48  CEO Since 2016      

Mark Gilreath Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of (0.47) % which means that for every 100 dollars spent on asset it generated loss of $0.47. This is way below average.
The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7 which is normal for its line of buisiness. EndoChoice Holdings has Current Ratio of 5.52 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Found 10 records

CEO Since

Walter RosebroughSteris Plc
James HawkinsNatus Medical Incorporated
Jeffrey BurbankNxstage Medical
Stephen RusckowskiQuest Diagnostics Incorporated
Robert PalmisanoWright Medical Group N V
AndreMichel BallesterLivaNova PLC
Dow WilsonVarian Medical Systems
Patrick SullivanInsulet Corporation
John GreischHill Rom Holdings
John GroetelaarsHill Rom Holdings

Entity Summary

EndoChoice Holdings, Inc., a medical device company, designs and commercializes various solutions for gastrointestinal caregivers in the United States and internationally. EndoChoice Holdings (GI) is traded on New York Stock Exchange in USA. It is located in EndoChoice Holdings, Inc.Alpharetta, GA and employs 501 people.

EndoChoice Holdings Leadership Team

Simon MA, CFO
Scott Huennekens, Chairman of the Board
David Kaufman, Director
David Mowry, Director
Douglas Ladd, Chief Marketing Officer
Rurik Vandevenne, Director
Simon Tam, President CEO, Director
John Smyth, Director
James Balkcom, Director
Kevin Rubey, COO
Mark Gilreath, Founder, CEO and President and Director
Scott Davis, Director
Uri Geiger, Director
Scott Carter, Director
David Gill, CFO
Craig Walker, Director
William Enquist, Director
Michael Ballanger, Director
John Barr, Chairman of the Board, Interim CEO
Eric Schjelderup, Director

Stock Performance Indicators

Current Sentiment - GI

EndoChoice Holdings Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in EndoChoice Holdings. What is your opinion about investing in EndoChoice Holdings? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.